Literature DB >> 17071056

Altered expression of regulator of G-protein signalling 4 (RGS4) mRNA in the superior temporal gyrus in schizophrenia.

Nikola A Bowden1, Rodney J Scott, Paul A Tooney.   

Abstract

To identify altered mRNA expression of regulator of G-protein signalling 4 (RGS4) in the superior temporal gyrus (STG) in schizophrenia mRNA expression of RGS4 was measured from post-mortem STG tissue from 13 individuals with schizophrenia and 13 matched non-psychiatric controls using relative real-time PCR. Significantly decreased expression of RGS4 mRNA in the STG in schizophrenia was identified in 10 of the 13 matched pairs. Altered expression of RGS4 in cortical regions previously implicated in schizophrenia, such as the STG further supports the notion of RGS4 as a potential genetic and functional biological marker of schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17071056     DOI: 10.1016/j.schres.2006.09.003

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  19 in total

Review 1.  Gene expression in the etiology of schizophrenia.

Authors:  Nicholas J Bray
Journal:  Schizophr Bull       Date:  2008-03-11       Impact factor: 9.306

Review 2.  Multifunctional pharmacotherapy: what can we learn from study of selective serotonin reuptake inhibitor augmentation of antipsychotics in negative-symptom schizophrenia?

Authors:  Henry Silver; Yael Chertkow; Orly Weinreb; Lena Danovich; Moussa Youdim
Journal:  Neurotherapeutics       Date:  2009-01       Impact factor: 7.620

3.  RNA-binding protein HuR regulates RGS4 mRNA stability in rabbit colonic smooth muscle cells.

Authors:  Fang Li; Danielle Y Hu; Shu Liu; Sunila Mahavadi; William Yen; Karnam S Murthy; Kamel Khalili; Wenhui Hu
Journal:  Am J Physiol Cell Physiol       Date:  2010-09-29       Impact factor: 4.249

4.  Brain RGS4 and RGS10 protein expression in schizophrenia and depression. Effect of drug treatment.

Authors:  G Rivero; A M Gabilondo; J A García-Sevilla; L F Callado; R La Harpe; B Morentin; J J Meana
Journal:  Psychopharmacology (Berl)       Date:  2012-10-24       Impact factor: 4.530

5.  Cloning and characterization of rabbit Rgs4 promoter in gut smooth muscle.

Authors:  Fang Li; Karnam S Murthy; Kamel Khalili; Wenhui Hu
Journal:  Gene       Date:  2009-11-26       Impact factor: 3.688

Review 6.  R4 RGS proteins: regulation of G-protein signaling and beyond.

Authors:  Geetanjali Bansal; Kirk M Druey; Zhihui Xie
Journal:  Pharmacol Ther       Date:  2007-10-05       Impact factor: 12.310

7.  The role of cerebellar genes in pathology of autism and schizophrenia.

Authors:  S Hossein Fatemi; Teri J Reutiman; Timothy D Folsom; Robert W Sidwell
Journal:  Cerebellum       Date:  2008       Impact factor: 3.847

8.  Linkage disequilibrium patterns and functional analysis of RGS4 polymorphisms in relation to schizophrenia.

Authors:  Kodavali V Chowdari; Mikhil Bamne; Joel Wood; Michael E Talkowski; Karoly Mirnics; Pat Levitt; David A Lewis; Vishwajit L Nimgaonkar
Journal:  Schizophr Bull       Date:  2007-05-21       Impact factor: 9.306

9.  Activation of the JAK-STAT pathway is necessary for desensitization of 5-HT2A receptor-stimulated phospholipase C signalling by olanzapine, clozapine and MDL 100907.

Authors:  Rakesh K Singh; Ying Dai; Jeff L Staudinger; Nancy A Muma
Journal:  Int J Neuropsychopharmacol       Date:  2008-10-31       Impact factor: 5.176

10.  Schizophrenia is associated with an increase in cortical microRNA biogenesis.

Authors:  N J Beveridge; E Gardiner; A P Carroll; P A Tooney; M J Cairns
Journal:  Mol Psychiatry       Date:  2009-09-01       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.